ZILRETTA is the first and only FDA-approved treatment for osteoarthritis knee pain to use extended-release microsphere technology.

Down arrow for website navigation

ZILRETTA microspheres slowly release pain medication into the knee joint for about 3 months

Image shows a multitude of blue spheres over a timeline that starts at injection day and goes up to month one, two, and three

See how ZILRETTA microsphere technology works

Icon representative of a drop of blood being analyzed

News for people with Type 2 diabetes

In a small clinical trial of people with controlled Type 2 diabetes, minimal elevation in their blood glucose level was experienced after treatment with ZILRETTA vs another corticosteroid.

Note: Corticosteroids may increase blood glucose levels. Individual patient experience may differ from what was seen in this study.

The clinical significance of this information is unknown.

See how ZILRETTA worked for these five people